Your browser doesn't support javascript.
loading
The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
Bajetta, E; Zilembo, N; Noberasco, C; Martinetti, A; Mariani, L; Ferrari, L; Buzzoni, R; Greco, M; Bartoli, C; Spagnoli, I; Danesini, G M; Artale, S; Paolini, J.
Affiliation
  • Bajetta E; Division of Medical Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Eur J Cancer ; 33(4): 587-91, 1997 Apr.
Article in En | MEDLINE | ID: mdl-9274439
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Aromatase Inhibitors / Estrogen Antagonists / Androstadienes / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 1997 Type: Article Affiliation country: Italy
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Aromatase Inhibitors / Estrogen Antagonists / Androstadienes / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 1997 Type: Article Affiliation country: Italy